Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2025 19:21 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Investors: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.

Robbins LLP announces a class action against Spectrum Pharmaceuticals (SPPI) for alleged securities law violations tied to its cancer drug apaziquone.
December 28, 2022 17:18 ET | Source: Robbins LLP

Class Action Involving Spectrum Pharmaceuticals, Inc. (SPPI): Contact Robbins LLP if You Incurred Significant Financial Harm from Your Investment in Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
December 14, 2022 17:18 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
December 08, 2022 12:42 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...